We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-7.78%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.62B
AUM Growth
-$116M
(-6.7%)
Cap. Flow
+$444M
Cap. Flow
% of AUM
27.45%
Top 10 Holdings %
Top 10 Hldgs %
37.93%
Holding
108
New
37
Increased
28
Reduced
11
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$54.3M |
| 2 |
Energizer
ENR
|
+$39.6M |
| 3 |
Amazon
AMZN
|
+$36.8M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$35.3M |
| 5 |
Avalo Therapeutics
AVTX
|
+$27.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams-Sonoma
WSM
|
+$32.8M |
| 2 |
AutoZone
AZO
|
+$29.4M |
| 3 |
Envista
NVST
|
+$25.1M |
| 4 |
Biogen
BIIB
|
+$21.2M |
| 5 |
Estee Lauder
EL
|
+$20.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.87% |
| 2 | Consumer Staples | 13.75% |
| 3 | Consumer Discretionary | 13.46% |
| 4 | Technology | 4.19% |
| 5 | Industrials | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$317B
| $23.1M | 1.43% |
314,400
+230,560
| +275% | +$18.1M |
|
27
CVS Health
CVS
$126B
| $22.4M | 1.39% |
+378,000
| New | +$25.2M |
|
28
Dollar Tree
DLTR
$24.7B
| $22.4M | 1.39% |
+305,183
| New | +$26M |
|
29
Frontdoor
FTDR
$5.36B
| $22.3M | 1.38% |
640,000
+140,000
| +28% | +$5.96M |
|
30
Pfizer
PFE
$147B
| $22.1M | 1.37% |
+714,612
| New | +$24.3M |
|
31
Campbell Soup
CPB
$6.87B
| $22.1M | 1.36% |
+478,000
| New | +$23M |
|
32
UnitedHealth
UNH
$375B
| $21.9M | 1.36% |
+88,000
| New | +$24.2M |
|
|
CPRX
33
DELISTED
Catalyst Pharmaceutical
CPRX
| $20.8M | 1.29% |
5,400,000
+300,000
| +6% | +$1.23M |
|
34
Voyager Therapeutics
VYGR
$187M
| $20.5M | 1.27% |
2,236,000
+612,000
| +38% | +$7.02M |
|
35
Edgewell Personal Care
EPC
$1.35B
| $19.3M | 1.19% |
+800,000
| New | +$23.9M |
|
|
36
Biogen
BIIB
$30.5B
| $18.4M | 1.13% |
58,000
-70,000
| -55% | -$21.2M |
|
37
Lantheus
LNTH
$6.61B
| $16.9M | 1.04% |
+1,324,000
| New | +$21.2M |
|
38
Target
TGT
$67.1B
| $16.7M | 1.03% |
+180,000
| New | +$20M |
|
39
Mondelez International
MDLZ
$79.9B
| $15M | 0.93% |
+300,000
| New | +$16.3M |
|
40
AptarGroup
ATR
$8.69B
| $14.9M | 0.92% |
+150,000
| New | +$16.3M |
|
41
Madrigal Pharmaceuticals
MDGL
$11.9B
| $14.4M | 0.89% |
216,000
+56,000
| +35% | +$4.67M |
|
42
Carter's
CRI
$1.47B
| $14.1M | 0.87% |
+215,000
| New | +$20.7M |
|
43
Visa
V
$688B
| $14M | 0.87% |
+87,000
| New | +$16.4M |
|
|
AVYA
44
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $12.9M | 0.8% |
1,592,000
-100,000
| -6% | -$1.19M |
|
|
45
CALL
Edgewell Personal Care
EPC
$1.35B
| $12M | 0.74% |
5,000
-10,000
| -67% | -$299K |
|
46
Colgate-Palmolive
CL
$74.4B
| $11.9M | 0.74% |
+180,000
| New | +$12.7M |
|
47
Kimberly-Clark
KMB
$37.3B
| $11.3M | 0.7% |
+88,000
| New | +$12.2M |
|
48
Chipotle Mexican Grill
CMG
$43.7B
| $11M | 0.68% |
839,950
-847,150
| -50% | -$13.4M |
|
49
Assembly Biosciences
ASMB
$526M
| $10.7M | 0.66% |
60,333
-36,000
| -37% | -$7.72M |
|
|
TWNK
50
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $10.7M | 0.66% |
1,000,000
-28,000
| -3% | -$356K |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q1 2020 Portfolio in Review
As of Q1 2020, Armistice Capital held 108 positions worth $1.62B, down 6.7% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Armistice Capital deployed $444M of net new capital in Q1 2020, opening 37 new positions and adding to 28 existing holdings. Its largest new stake was Burlington: 258,004 shares worth $40.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 42% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Biogen, an estimated $21.2M trimmed.
- Armistice Capital's largest Q1 2020 buy was Burlington: 258,004 shares worth $40.9M.
- Armistice Capital added most to Amazon in Q1 2020, an estimated $36.8M increase.
- Armistice Capital's biggest Q1 2020 reduction was Biogen, cutting an estimated $21.2M.
- Armistice Capital fully exited Williams-Sonoma in Q1 2020, selling an estimated $32.8M.
- Armistice Capital's ten largest holdings make up 38% of its $1.62B portfolio in Q1 2020.
- Armistice Capital opened 37 new positions and closed 29 in Q1 2020.
- Armistice Capital's portfolio value fell 6.7% quarter-over-quarter to $1.62B.
Based on Armistice Capital's 13F filing for Q1 2020, filed 15 May 2020.